The creation of biotech startups: evolution not revolution

January 3, 2021 0 Comments

In favor of seed-stage de-risking, but pragmatic about what to expect after seed stage. Bruce Booth of Atlas Ventures offers counterpoints to the visions that biotech future proposed by tech investors at YC and a16z. | learn more